These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15844284)

  • 1. Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing.
    Hewitson P; Austoker J
    BJU Int; 2005 Apr; 95 Suppl 3():16-32. PubMed ID: 15844284
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
    Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
    J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up.
    Volk RJ; Spann SJ; Cass AR; Hawley ST
    Ann Fam Med; 2003; 1(1):22-8. PubMed ID: 15043176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the manner in which information about prostate-specific antigen (PSA) testing is presented affect screening rates?
    Lockman AR
    J Fam Pract; 2001 Oct; 50(10):898. PubMed ID: 11674897
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoting informed decision making about prostate cancer screening.
    Chan EC
    Compr Ther; 2001; 27(3):195-201. PubMed ID: 11569319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of informed consent on patient interest in prostate-specific antigen screening.
    Wolf AM; Nasser JF; Wolf AM; Schorling JB
    Arch Intern Med; 1996 Jun; 156(12):1333-6. PubMed ID: 8651843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of shared decision making for prostate cancer screening.
    Volk RJ; Cass AR; Spann SJ
    Arch Fam Med; 1999; 8(4):333-40. PubMed ID: 10418541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
    Gattellari M; Ward JE
    J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for prostate cancer. How can patients give informed consent?
    Marshall KG
    Can Fam Physician; 1993 Nov; 39():2385-90. PubMed ID: 7505673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared decision making, contextualized.
    Ferrer RL; Gill JM
    Ann Fam Med; 2013; 11(4):303-5. PubMed ID: 23835815
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for prostate cancer: informing men about their options.
    Mahon SM
    Clin J Oncol Nurs; 2005 Oct; 9(5):625-7. PubMed ID: 16235590
    [No Abstract]   [Full Text] [Related]  

  • 15. Preferences of elderly men for prostate-specific antigen screening and the impact of informed consent.
    Wolf AM; Schorling JB
    J Gerontol A Biol Sci Med Sci; 1998 May; 53(3):M195-200. PubMed ID: 9597051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informed consent for PSA testing.
    Brown V
    J Fam Pract; 1996 Sep; 43(3):234-5. PubMed ID: 8797747
    [No Abstract]   [Full Text] [Related]  

  • 17. Being screened for prostate cancer: a simple blood test or a commitment to treatment?
    Oliffe J
    Cancer Nurs; 2006; 29(1):1-8. PubMed ID: 16557114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial panel on informed consent for PSA screening.
    Ramsden AR; Chodak G
    Urology; 2003 Sep; 62(3):589. PubMed ID: 12946782
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness.
    Burack RC; Wood DP
    Med Clin North Am; 1999 Nov; 83(6):1423-42, vi. PubMed ID: 10584601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared decision making in the real world.
    Deber RB
    J Gen Intern Med; 1996 Jun; 11(6):377-8. PubMed ID: 8803747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.